<--- Back to Details
First PageDocument Content
Pharmaceutics / Pharmaceuticals policy / Food and Drug Administration / Therapeutics / Drug Master File / Abbreviated New Drug Application / Generic drug / New Drug Application / Pharmaceutical drug / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology
Pharmaceutics
Pharmaceuticals policy
Food and Drug Administration
Therapeutics
Drug Master File
Abbreviated New Drug Application
Generic drug
New Drug Application
Pharmaceutical drug
Pharmaceutical industry
Pharmaceutical sciences
Pharmacology

Microsoft Word - GDUFA Statutory Language[removed]docx

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 536,40 KB

Share Document on Facebook

Similar Documents

FINECURE PHARMACEUTICALS LIMITED NOMINATION AND REMUNERATION POLICY I. PREAMBLE

DocID: 1vhvU - View Document

For over 20 years, Health Policy Associates has been providing practical and highly efficient consulting solutions to companies involved in developing new medical device technologies, pharmaceuticals and biologics. Clin

DocID: 1vdpM - View Document

FINECURE PHARMACEUTICALS LIMITED POLICY ON ARCHIVAL OF DOCUMENTS 1. PREAMBLE The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR") came into force fr

DocID: 1v1UD - View Document

FINECURE PHARMACEUTICALS LTD. CIN: U24230GJ2005PLC045724 CORPORATE SOCIAL RESPONSIBILITY POLICY Registered Office:

DocID: 1uqeg - View Document

Privacy Policy Revised as of April 4, 2018 Welcome to www.minivelle.com, a web site owned by Noven Pharmaceuticals, Inc. (Noven, our, or we). This Privacy Policy is designed to tell you about our practices regarding coll

DocID: 1un1u - View Document